Skip to content

Active Exhalation Device Kit

by Respironics Inc.

Ref 1065659

Active Exhalation Device Kit (1065659) is a portable electric ventilator (EU MDD Class IIa; FDA Class II; FDA product code CBK, Ventilator, Continuous, Facility Use) made by Respironics Inc., registered in EUDAMED on 21 Jul 2026 (Basic UDI-DI B-00606959020764), cleared under FDA 510(k) K083526 on 13 Mar 2009 and listed in FDA GUDID since 28 Sep 2016 (UDI-DI 00606959020764), active as of 24 Oct 2026. 8 FDA recalls are linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K083526

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD EUDAMED NumberB-00606959020764 Basic UDI-DI 00606959020764UDI-DIDate21 Jul 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00606959020764 UDI-DI Date28 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Abbreviated NumberK083526 Date13 Mar 2009DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 24 Oct 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-00606959020764 registered 21 Jul 2026 Active
  • FDA 510(k) K083526 decided 13 Mar 2009 Active
  • FDA GUDID UDI-DI 00606959020764 listed 28 Sep 2016 Listed

Recalls

8 recalls · 3 ongoing · FDA

  • 2 recalls, same reason

    • Ongoing Z-0882-2023 FDA Class I initiated 7 Dec 2022
    • Ongoing Z-0884-2023 FDA Class I initiated 7 Dec 2022

    The replacement silicone sound abatement foam installed into some Trilogy 100 and Trilogy 200 devices may separate from the plastic backing to which it is attached. If this were to happen, the foam could potentially block air inlet, which could result in a reduction in delivered therapy volume or pressure and could cause the device to alarm.

    • Ongoing Z-1956-2021 FDA Class I initiated 14 Jun 2021

    The polyester-based polyurethane (PE-PUR) foam may degrade into particles which may enter the devices air pathway and be ingested or inhaled by the user, and the PE-PUR foam may off-gas certain chemicals.

    • Terminated Z-1065-2016 FDA Class II initiated 18 Jan 2016

    Software Issue

    • Terminated Z-1143-2014 FDA Class I initiated 11 Feb 2014

    Internal testing revealed a potentially defective component on the power management board that could affect the function of certain Trilogy Ventilators resulting in loss of therapy to patients.

    • Terminated Z-2024-2012 FDA Class I initiated 27 Apr 2012

    The specified Trilogy units are being recalled because of the potential for a faulty component in the power supply.

    • Terminated Z-0296-2012 FDA Unclassified (pre-2012) initiated 11 Oct 2011

    Trilogy 100, 200 and 202 units are being recalled due to low impeller press-force used during the manufacturing process. If the press force were low enough, theoretically the impeller could move up the shaft and come into contact with the inside of the blower housing/impeller enclosure. This may impact therapy.

    • Terminated Z-1896-2010 FDA Unclassified (pre-2012) initiated 10 Jun 2010

    It is possible that the battery could electrically short, resulting in a potential for fire or a thermal event.

Timeline

11 dated events

  1. Recall initiated FDA recalls Z-1896-2010
  2. Recall initiated FDA recalls Z-0296-2012
  3. Recall initiated FDA recalls Z-2024-2012
  4. Recall initiated FDA recalls Z-1143-2014
  5. Recall initiated FDA recalls Z-1065-2016
  6. Listed FDA GUDID 00606959020764
  7. Recall initiated FDA recalls Z-1956-2021
  8. Recall initiated FDA recalls Z-0882-2023
  9. Recall initiated FDA recalls Z-0884-2023
  10. Registered EUDAMED B-00606959020764

1 earlier event are in the sections above.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Active Exhalation Device Kit EUDAMED
Active Exhalation GUDID
Generic name
Portable electric ventilator
Model / Ref / Catalog
1065659, Active Exhalation Device Kit
Primary DI / UDI-DI
00606959020764
Basic UDI-DI
B-00606959020764
510(k) Number
FDA product code
CBK
EMDN code
Z12030103 Pulmonary ventilators for non–hospital use
GMDN term
Portable electric ventilator
Device class
Class IIa EUDAMED
Class II GUDID
Regulation number
868.5895
EU registration type
Legacy device (under a directive)
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / referenceEUDAMED
1065659
GUDID
Active Exhalation Device Kit
Device classEUDAMED
Class IIa
GUDID
Class II

Device class is stated on each registry's own scale: Class IIa in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under ANAESTHESIA AND PULMONARY VENTILATION SUPPORT INSTRUMENTS.

Other devices from Respironics Inc.

See all devices from Respironics Inc. →

Properties

  • Prescription use
  • Lot / batch number
Other properties (23, all answered No)